Sunday, December 01, 2024 10:02:05 PM
Thanks Chiugray,
If you're right about this, and it makes sense to me, if we have the capacity in numbers of EDEN units we can deploy, it will take practically no time before DCVax-L is being utilized by virtually millions of patients annually.
With a compendium listing permitting Doctors to utilize the vaccine with virtually all of the deadliest solid cancers word of improved efficacy will grow far faster than from trials which take years to reveal data. I suspect they'll want to do the trials to eventually gain expanded labels unless provisions already exist to change labels based on a massive amount of anecdotal evidence. I don't know if such possibilities exist, but frankly they should.
I've always believed that the regulators, all of them, should be able to react to what's right in front of their eyes. It shouldn't take millions of sheets of paper to prove to them what's directly in front of them.
Frankly I've had my doubts about how the incoming Administration will handle healthcare, but perhaps it could bring major improvements if those judging new products are permitted to get into what's being seen and not wait for applications that require a million or more pages and take years to prepare.
Who knows, perhaps even the right to try will become what it was intended to be with the change of Administrations.
Gary
If you're right about this, and it makes sense to me, if we have the capacity in numbers of EDEN units we can deploy, it will take practically no time before DCVax-L is being utilized by virtually millions of patients annually.
With a compendium listing permitting Doctors to utilize the vaccine with virtually all of the deadliest solid cancers word of improved efficacy will grow far faster than from trials which take years to reveal data. I suspect they'll want to do the trials to eventually gain expanded labels unless provisions already exist to change labels based on a massive amount of anecdotal evidence. I don't know if such possibilities exist, but frankly they should.
I've always believed that the regulators, all of them, should be able to react to what's right in front of their eyes. It shouldn't take millions of sheets of paper to prove to them what's directly in front of them.
Frankly I've had my doubts about how the incoming Administration will handle healthcare, but perhaps it could bring major improvements if those judging new products are permitted to get into what's being seen and not wait for applications that require a million or more pages and take years to prepare.
Who knows, perhaps even the right to try will become what it was intended to be with the change of Administrations.
Gary
Bullish
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
